Media coverage about Validus (NYSE:VR) has been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Validus earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave media headlines about the insurance provider an impact score of 47.1333350718455 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Validus (NYSE:VR) traded down $1.17 on Friday, hitting $48.01. The company’s stock had a trading volume of 1,070,000 shares, compared to its average volume of 686,158. Validus has a 1 year low of $41.15 and a 1 year high of $58.76. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.95 and a current ratio of 0.95.

Validus (NYSE:VR) last released its quarterly earnings results on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($3.30) by $0.08. Validus had a negative return on equity of 0.49% and a negative net margin of 1.38%. The firm had revenue of $407.00 million for the quarter, compared to the consensus estimate of $453.04 million. During the same quarter last year, the business posted $1.02 EPS. The company’s revenue for the quarter was up 24.3% on a year-over-year basis. analysts expect that Validus will post -0.16 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be paid a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 3.17%. The ex-dividend date of this dividend is Thursday, December 14th. Validus’s dividend payout ratio is -233.84%.

Several research analysts have weighed in on VR shares. Zacks Investment Research lowered Validus from a “hold” rating to a “strong sell” rating in a report on Thursday, September 28th. UBS reduced their target price on Validus from $50.00 to $48.00 and set a “neutral” rating on the stock in a report on Monday, October 2nd. TheStreet lowered Validus from a “b” rating to a “c+” rating in a report on Wednesday, October 11th. ValuEngine raised Validus from a “sell” rating to a “hold” rating in a research note on Friday, October 20th. Finally, BidaskClub downgraded Validus from a “sell” rating to a “strong sell” rating in a research note on Friday, August 18th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the stock. Validus has a consensus rating of “Hold” and a consensus price target of $54.83.

In related news, CEO Lixin Zeng sold 26,136 shares of Validus stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $52.10, for a total value of $1,361,685.60. Following the sale, the chief executive officer now owns 57,855 shares of the company’s stock, valued at $3,014,245.50. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Kean Driscoll sold 6,875 shares of Validus stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $50.30, for a total value of $345,812.50. The disclosure for this sale can be found here. Company insiders own 2.33% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Validus (VR) Stock Price” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Insider Buying and Selling by Quarter for Validus (NYSE:VR)

Receive News & Stock Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related stocks with our FREE daily email newsletter.